The Tissue Viability Society (TVS) will be 40 years old in 2020. The society has many subscription paying members some of whom have given their support financially and actually for a decade or more. In preparation for our birthday we issued a survey to our members in order to identify what the next steps for […]

This guideline sets out an antimicrobial prescribing strategy for adults with leg ulcer infection. It aims to optimise antibiotic use and reduce antibiotic resistance. Click here to view the published information

The Medicines and Healthcare products Regulatory Agency (MHRA) is an executive agency of the Department of Health. They are responsible for regulating all medical devices and medicines in the UK by ensuring they work and are acceptably safe. A large part of their work consists of investigating adverse incidents that are reported and they encourage […]

We are delighted to announce that Pressure Relieving Support Surfaces for Pressure Ulcer Prevention (PRESSURE 2): Clinical and Health Economic Results of a Randomised Controlled Trial have now been published by The Lancet and can be viewed by clicking here Huge thanks to the Trust research teams and patients involved.

BACKGROUND At the Tissue Viability Society (TVS) we’ve served the wound care community for over 39 years. The Tissue Viability Society started as a regional group in 1979, becoming a national society in 1981 and gained its charitable status in the mid 1990s. Today it is an independent registered charity run by a body of […]

The Journal of Tissue Viability (JTV) is the official publication of the Tissue Viability Society and we are proud to announce that the impact factor is  2.831. This is an increase from the previous year of 1.925 and ranks the journal #2 in the JCR Nursing category of 120 journals SCIE database. Also ranking 22/66 […]

This guideline covers assessing and managing urinary incontinence and pelvic organ prolapse in women aged 18 and over. It also covers complications associated with mesh surgery for these conditions. In June 2019, NICE withdrew recommendations 1.8.21 and 1.8.22 on the use of synthetic polypropylene or biological mesh insertion for women with recurrent anterior vaginal wall […]